HIM
UTHR icon

Hillsdale Investment Management’s United Therapeutics UTHR Stock Holding History

Hillsdale Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,850
Closed -$407K – 681
2023
Q4 		$407K Hold
1,850
– – 0.03% 335
2023
Q3 		$418K Buy
1,850
+50
+3% +$11.5K 0.04% 310
2023
Q2 		$397K Buy
1,800
+50
+3% +$11.1K 0.04% 294
2023
Q1 		$392K Buy
1,750
+1,700
+3,400% +$419K 0.03% 381
2022
Q4 		$13.9K Hold
50
– – ﹤0.01% 511
2022
Q3 		$10K Hold
50
– – ﹤0.01% 513
2022
Q2 		$12K Buy
+50
New +$10.2K ﹤0.01% 490
2021
Q3 		– Sell
-65
Closed -$12K – 643
2021
Q2 		$12K Sell
65
-3,600
-98% -$686K ﹤0.01% 529
2021
Q1 		$613K Sell
3,665
-450
-11% -$75K 0.05% 310
2020
Q4 		$625K Buy
4,115
+50
+1% +$6.56K 0.06% 278
2020
Q3 		$411K Buy
4,065
+100
+3% +$11K 0.04% 363
2020
Q2 		$480K Buy
+3,965
New +$446K 0.04% 329
2015
Q2 		– Sell
-2,100
Closed -$362K – 565
2015
Q1 		$362K Buy
2,100
+500
+31% +$76.2K 0.09% 206
2014
Q4 		$207K Sell
1,600
-100
-6% -$12.9K 0.05% 325
2014
Q3 		$219K Buy
+1,700
New +$175K 0.07% 293
2014
Q2 		– Sell
-100
Closed -$9K – 596
2014
Q1 		$9K Hold
100
– – ﹤0.01% 488
2013
Q4 		$11K Hold
100
– – ﹤0.01% 470
2013
Q3 		$8K Hold
100
– – ﹤0.01% 475
2013
Q2 		$7K Buy
+100
New +$6.44K ﹤0.01% 491

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Hillsdale Investment Management's UTHR Position: Q1 2024 in Review

Hillsdale Investment Management sold out of United Therapeutics (UTHR) in Q1 2024, closing a stake of 1,850 shares — an estimated $407K sold.

Hillsdale Investment Management first reported a position in UTHR in Q2 2013 and held it in 19 quarters. The position peaked at $625K in Q4 2020. 525 funds tracked by Wall St. Rank hold UTHR as of Q1 2024.

  • Hillsdale Investment Management reported no remaining United Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 1,850 United Therapeutics shares in Q1 2024, an estimated $407K.
  • Hillsdale Investment Management first reported a position in United Therapeutics in Q2 2013 and held it in 19 quarters.
  • Hillsdale Investment Management's United Therapeutics position peaked at $625K in Q4 2020.
  • 525 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2024.

Based on Hillsdale Investment Management's 13F filing for Q1 2024, filed 10 May 2024.